Diabetic Footwear Market Share

  • Report ID: 51
  • Published Date: Jun 13, 2025
  • Report Format: PDF, PPT

Diabetic Footwear Market Regional Analysis:

The North America diabetic footwear market is projected to hold largest revenue share by the end of 2034, backed by increasing prevalence of diabetes, and the significantly increasing geriatric population in the region. Moreover, there has been a rising awareness among people related to diabetics and the use of footwear for the comfort of the foot.

As per a report provided by the Centers for Disease Control and Prevention (CDC), in the United States, diabetes affects approximately 37.3 million people, which represents nearly 11% of the US population. Moreover, the diabetic ulcer treatment recommended by the doctors includes wearing footwear that reduces the pain of the patients, followed by the rising number of people suffering from the chronic pain in the North America region.

Diabetic Footwear Market Share

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic footwear is estimated at USD 9.27 billion.

Diabetic Footwear Market size was valued at USD 8.76 billion in 2024 and is set to exceed USD 16.91 billion by 2034, registering over 6.8% CAGR during the forecast period i.e., between 2025-2034.

North America is anticipated to hold largest industry share by 2034.

The key market players include Dr.zens Research Inc., duna srl, DJO Global, Inc., Grace Guangzhou Health Shoes Co., Ltd, DARCO International, Inc., Apex Foot Health Industries, LLC, Podartis srl Unipersonale, Orthofeet, Inc., Aetrex Worldwide, Inc., Apis Footwear Company.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos